Real-time enrollment status for this acute myeloid leukemia clinical trial
Current Status
Recruiting
Checked: August 31, 2026 at 1:45 AM UTC
| NCT Number | NCT05429632 |
| Recruiting Status | Recruiting |
| Condition | Acute Myeloid Leukemia |
| Phase | PHASE3 |
| Target Enrollment | 366 participants |
| Active Locations | 21 sites in the US |
| Sponsor | Priothera SAS |
| Last Updated on CT.gov | July 17, 2026 (Jul 17, 2026) |
As of August 31, 2026: Clinical trial NCT05429632 is currently recruiting participants. This phase3 study for acute myeloid leukemia is actively seeking new participants at 21 locations across the United States. The study is sponsored by Priothera SAS. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05429632 is actively recruiting participants as of August 31, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 21 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05429632 was last updated Jul 17, 2026 (July 17, 2026). HelloStudys verifies this status automatically.